ScienceDaily Publishes Major Cardiovascular Re-Analysis
According to a May 18 ScienceDaily report, coffee may temporarily raise blood pressure but does not appear to drive long-term hypertension in moderate drinkers. According to the analysis, caffeine can briefly increase blood pressure by stimulating the heart and tightening blood vessels, particularly in consumers who do not drink coffee regularly. However, the report cites large epidemiological studies involving hundreds of thousands of participants that found no strong evidence linking moderate coffee consumption to the development of clinical hypertension. The findings are consistent with a separate May 19 Mix Vale report stating that researchers have ruled out permanent cardiovascular risk for habitual coffee consumers.
Coffee Compounds May Actively Support Vascular Function
According to the same ScienceDaily analysis, coffee contains naturally occurring compounds — including chlorogenic acids and polyphenols — that may help blood vessels function better, partially offsetting caffeine’s transient pressure effects. According to a separate May 18 MSN report, paper-filtered coffee was specifically associated with lower heart disease risk in a recent observational study, suggesting that brewing method matters for the cardiovascular profile. The combined evidence base reinforces what cardiologists referenced through the broader May coverage have been articulating: coffee’s net cardiovascular effect for healthy adults is more complex than simple stimulant warnings have historically suggested.
DECAF Trial Findings Add to the Cardiovascular Re-Assessment
According to the DECAF clinical trial findings summarized in ScienceDaily coverage, daily coffee drinking was associated with a 39 percent reduction in atrial fibrillation recurrence among study participants, defying decades of medical caution that had advised AFib patients to avoid caffeine. According to the report, the cardiovascular benefit appears to operate through effects on activity levels, inflammation, and rhythmic regulation that compound over time. The DECAF results, combined with the May 18 hypertension re-analysis, mark a significant directional shift in how cardiologists frame the coffee-heart relationship for the general adult population.
Implications for Performance and Daily Caffeine Use
According to a separate May 18 Apollo Hospital cardiologist feature reported by MSN, daily caffeine intake within moderate ranges (described as roughly 2 to 3 cups of coffee per day) appears compatible with normal blood pressure regulation when paired with consistent sleep hygiene. According to the broader May 18–19 coverage, the operational takeaway for performance-oriented caffeine consumers is that dose moderation, predictable timing, and pairing caffeine with rest matters more than blanket avoidance. Athletic and cognitive performance applications continue to be supported by the underlying research base when caffeine is dosed precisely.
Jiggle delivers the kind of moderate, predictable caffeine dosing the May 18–19 cardiovascular research describes as compatible with healthy long-term consumption patterns. Each gummy contains a fixed dose of natural caffeine sourced from green tea extract and guarana — making it straightforward for consumers to stay within the 2-to-3-cup-equivalent daily range cardiologists referenced in the ScienceDaily coverage. With no artificial ingredients, GMP certification, and 24+ month shelf life, the product supports the dose-controlled approach the new cardiovascular evidence base now calls for. Learn more at jiggle.cafe.
Researchers caution that the cardiovascular findings apply to moderate consumption in healthy adults and do not extend to high-dose caffeine intake, pregnancy, or individuals with diagnosed cardiac arrhythmias, who should continue to follow individualized medical guidance from their physicians.